E-LIB Suche - Ergebnisse für: Heigener, David

1

Comparative evaluation of PD‐L1 expression in cytology impr..:

Abdo, Mustafa ; Belloum, Yassine ; Heigener, David...
Molecular Oncology. 17 (2023) 5 - p. 737-746 , 2023

Link: https://doi.org/10.1002/..

2

Immune checkpoint blockade in small cell lung cancer:

Tay, Rebecca Y. ; Heigener, David ; Reck, Martin.
Lung Cancer. 137 (2019) - p. 31-37 , 2019

Link: https://doi.org/10.1016/..

3

Low-Molecular-Weight Heparin Versus Placebo for the Prevent..:

Haas, Sylvia K. ; Freund, Mathias ; Heigener, David...
Clinical and Applied Thrombosis/Hemostasis. 18 (2012) 2 - p. 159-165 , 2012

Link: https://doi.org/10.1177/..

4

A cross-market cost comparison of erlotinib versus pemetrex..:

Nuijten, Mark J.C. ; de Castro Carpeño, Javier ; Chouaid, Christos...
Lung Cancer. 76 (2012) 3 - p. 465-471 , 2012

Link: https://doi.org/10.1016/..

5

Long-Term Safety and Tolerability of Sorafenib in Patients ..:

Adjei, Alex A. ; Blumenschein Jr., George R. ; Mandrekar, Sumithra...
Clinical Lung Cancer. 12 (2011) 4 - p. 212-217 , 2011

Link: https://doi.org/10.1016/..

6

Efficacy and safety of bronchoscopic laser therapy in patie..:

Hermes, Andreas ; Heigener, David ; Gatzemeier, Ulrich..
The Clinical Respiratory Journal. 6 (2011) 2 - p. 67-71 , 2011

Link: https://doi.org/10.1111/..

7

Sunitinib in combination with gemcitabine plus cisplatin fo..:

Reck, Martin ; Frickhofen, Norbert ; Cedres, Susana...
Lung Cancer. 70 (2010) 2 - p. 180-187 , 2010

Link: https://doi.org/10.1016/..

8

Immune Checkpoint Inhibition in Non-metastatic Non-small Ce..:

Heigener, David F. ; Reck, Martin
Drugs. 79 (2019) 18 - p. 1937-1945 , 2019

Link: https://doi.org/10.1007/..

9

Second-Line Treatment Selection in Patients With Non–Small-..:

Girard, Nicolas ; Corral, Jesus ; Cortinovis, Diego.
Clinical Lung Cancer. 18 (2017) 2 - p. e89-e97 , 2017

Link: https://doi.org/10.1016/..

10

Efficacy and Safety of Nintedanib Plus Docetaxel in Patient..:

Gottfried, Maya ; Bennouna, Jaafar ; Bondarenko, Igor...
Targeted Oncology. 12 (2017) 4 - p. 475-485 , 2017

Link: https://doi.org/10.1007/..

11

Afatinib in Non-Small Cell Lung Cancer Harboring Uncommon E..:

Heigener, David F. ; Schumann, Christian ; Sebastian, Martin...
The Oncologist. 20 (2015) 10 - p. 1167-1174 , 2015

Link: https://doi.org/10.1634/..

12

Weekly and every 2 weeks cetuximab maintenance therapy afte..:

Heigener, David F. ; Pereira, José Rodrigues ; Felip, Enriqueta...
Targeted Oncology. 10 (2014) 2 - p. 255-265 , 2014

Link: https://doi.org/10.1007/..

13

Prospective, multicenter, randomized, independent-group, op..:

Heigener, David F. ; von Pawel, Joachim ; Eschbach, Corinna...
Lung Cancer. 80 (2013) 3 - p. 319-325 , 2013

Link: https://doi.org/10.1016/..

14

The gefitinib long-term responder (LTR)—A cancer stem-like ..:

Gottschling, Sandra ; Herpel, Esther ; Eberhardt, Wilfried E.E....
Lung Cancer. 77 (2012) 1 - p. 183-191 , 2012

Link: https://doi.org/10.1016/..

15

Response to Letter to the Editor:

Bischoff, Helge G. ; Heigener, David F. ; Walzer, Stefan.
Lung Cancer. 71 (2011) 2 - p. 245 , 2011

Link: https://doi.org/10.1016/..